7 assets in Developmental And Epileptic Encephalopathy

Therapeutic assets addressing Developmental And Epileptic Encephalopathy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Bexicaserin Developmental And Epileptic Encephalopathy	Longboard Pharmaceuticals	P3	BB (70)
Elsunersen Developmental And Epileptic Encephalopathy	Praxis Precision Medicines	P3	B (60)
Nbi-827104 Developmental And Epileptic Encephalopathy	Neurocrine Biosciences	P2	CCC (55)
Melatonin Developmental And Epileptic Encephalopathy	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.	P2	CCC (53)
S230815 Developmental And Epileptic Encephalopathy	Institut de Recherches Internationales Servier	P1/2	CCC (48)
Stiripentol Developmental And Epileptic Encephalopathy	Biocodex	P1	CC (47)
Glycerol Phenylbutyrate Developmental And Epileptic Encephalopathy	Weill Medical College of Cornell University	Early P1	C (39)